ANAVEX

anavex-logo

Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTORโ„ข platform. The Anavex portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. The companyโ€™s lead drug candidate for Alzheimerโ€™s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose (SAD) clinical trial. The company has also started scale-up manufacturing for ANAVEX 1-41, its second lead compound, targeting depression and AD. With sufficient quantities of ANAVEX 1-41 in hand, the company will be in a position to advance the program and begin preclinical studies on large animals in the near term.

#SimilarOrganizations #People #Financial #Event #Website #More

ANAVEX

Social Links:

Industry:
Biopharma Biotechnology Health Care Manufacturing Therapeutics

Founded:
2006-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.anavex.com

Total Employee:
1+

Status:
Active

Contact:
14164890092

Email Addresses:
[email protected]

Total Funding:
62.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sitelinks Search Box GStatic Google Static Content COVID-19 Sectigo SSL


Similar Organizations

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.


Current Advisors List

michael-gold_image

Michael Gold Scientific Advisory Board @ Anavex
Advisor

tangui-nicolas-maurice_image

Tangui Nicolas Maurice Scientific Advisory Board @ Anavex
Advisor

paul-aisen_image

Paul Aisen Scientific Advisory Board @ Anavex
Advisor

jeffrey-cummings_image

Jeffrey Cummings Scientific Advisory Board @ Anavex
Advisor

john-harrison_image

John Harrison Scientific Advisory Board @ Anavex
Advisor

not_available_image

Ottavio Arancio Scientific Advisory Board @ Anavex
Advisor

Current Employees Featured

christopher-u-missling_image

Christopher U. Missling
Christopher U. Missling President & CEO @ Anavex
President & CEO
2013-07-01

not_available_image

Walter E Kaufmann
Walter E Kaufmann Chief Scientific Officer @ Anavex
Chief Scientific Officer
2022-01-01

not_available_image

Tom Skarpelos
Tom Skarpelos Director @ Anavex
Director

not_available_image

Edward R Hammond
Edward R Hammond Chief Medical Officer @ Anavex
Chief Medical Officer
2022-01-01

Founder


not_available_image

Tom Skarpelos

Stock Details


Company's stock symbol is NASDAQ:AVXL

Investors List

deep-track-capital_image

Deep Track Capital

Deep Track Capital investment in Post-IPO Equity - Anavex

Official Site Inspections

http://www.anavex.com Semrush global rank: 1.81 M Semrush visits lastest month: 12.54 K

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Anavex"

Investors - Anavex Life Sciences

Learn more about how the team at Anavex Life Sciences strive to produce sustained strong performance and shareholder value.See details»

Steven P. Neilson - Vice President Clinical Operations at Anavex Life ...

Steven P. has held various senior roles and has a strong background in clinical operations. Their most recent position was as the Vice President of Clinical Operations at Anavex Life Sciences, โ€ฆSee details»

About Us | Anavex Life Sciences

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments.See details»

Anavex Life Sciences - Leadership Team | The Org

The Leadership Team at Anavex Life Sciences is responsible for setting the strategic direction of the company, overseeing clinical development, regulatory compliance, and operational efficiency.See details»

Anavex - Crunchbase Company Profile & Funding

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.See details»

Corporate Governance - Anavex Life Sciences

Corporate governance documents available for download and review.See details»

Anavex - Contacts, Employees, Board Members, Advisors & Alumni

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.See details»

Senior Vice President, CMC at Anavex Life Sciences - The โ€ฆ

Selvey's most recent position is as the Senior Vice President of CMC at Anavex Life Sciences, which they began in 2018 and continues to hold. Alani Selvey pursued a Ph.D. in Physical Chemistry at Duke University, although the exact start and end โ€ฆSee details»

Nell Rebowe - Director of Business Development at Anavex Life

View Nell Rebowe at Anavex Life Sciences on The OrgSee details»

Anavex Life Sciences : Corporate Presentation July 2025

Jul 23, 2025 Anavex Life Sciences Corp. published this content on July 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), โ€ฆSee details»

Anavex Life Sciences Org Chart + Executive Team - The Official Board

The org chart of Anavex Life Sciences contains its 12 main executives including Christopher Missling and Terrie Kellmeyer.See details»

Anavex Life Sciences - Regulatory Affairs and Strategy | The Org

The Regulatory Affairs and Strategy team at Anavex Life Sciences plays a crucial role in guiding the development of therapeutics through regulatory processes, ensuring compliance with health โ€ฆSee details»

Investor Material - Anavex Life Sciences

Dec 23, 2024 At Anavex Life Sciences, we strive to produce sustained strong performance and shareholder value.See details»

Anavex Life Sciences : Corporate Presentation July 2025

Jul 23, 2025 Cumulative costs of Alzheimer's and dementia care from 2015 to 2050 PEOPLE LIVING WITH DEMENTIA AROUND THE WORLD Source: World Alzheimer's Report 4 Anavex โ€ฆSee details»

Anavex Life Sciences - The Org

Anavex Life Sciences Corp. (www.anavex.com) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and โ€ฆSee details»

Anavex Life Sciences - Teams | The Org

Explore teams at Anavex Life Sciences. View team members, open roles, and company details.See details»

Anavex Life Sciences Corp. Reports Q1 Fiscal 2025 Financial ... - Nasdaq

Feb 12, 2025 Anavex Life Sciences reports Q1 2025 financial results and hosts a webcast discussing advancements in Alzheimerโ€™s treatment.See details»

Anavex Life Sciences Corp. - Drug pipelines, Patents ... - Patsnap

Jul 6, 2025 Explore Anavex Life Sciences Corp. with its drug pipeline, therapeutic area, technology platform, 14 clinical trials, 136 news, and 9 literature, Disease Domain:Nervous System Diseases, โ€ฆSee details»

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health โ€ฆ

Feb 24, 2025 Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of โ€ฆSee details»

Anavex Life Sciences Management Team | Org Chart - RocketReach

The Anavex Life Sciences management team includes Christopher Missling (President and CEO), Emma Smith (Human Resources Manager), and Terrie Kellmeyer (Senior Vice President Clinical โ€ฆSee details»

linkstock.net © 2022. All rights reserved